VRTX
Vertex Pharmaceuticals Incorporated
Stock
$504.73−2.01 (−0.40%)Close Oct 2, 2026
- EBITDA, 2025
- $4.4B
- 5-year CAGR
- +8.1%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $4.4B | — |
| 2024 | −$26M | — |
| 2023 | $4.0B | −9.9% |
| 2022 | $4.5B | +53.2% |
| 2021 | $2.9B | −2.0% |
| 2020 | $3.0B | +127.4% |
| 2019 | $1.3B | +84.3% |
| 2018 | $708M | +283.2% |
| 2017 | $185M | +158.8% |
| 2016 | $71M | — |
| 2015 | −$405M | — |
| 2014 | −$629M | — |
| 2013 | −$562M | — |
| 2012 | $85M | −43.0% |
| 2011 | $149M | — |
| 2010 | −$666M | — |
| 2009 | −$584M | — |
| 2008 | −$431M | — |